- Home
- BMY vs BTI Comparison
BMY vs BTI Comparison
Compare BMY & BTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BMY
- BTI
- Stock Information
- Founded
- BMY 1887
- BTI 1902
- Country
- BMY United States
- BTI United Kingdom
- Employees
- BMY N/A
- BTI N/A
- Industry
- BMY Biotechnology: Pharmaceutical Preparations
- BTI Medicinal Chemicals and Botanical Products
- Sector
- BMY Health Care
- BTI Health Care
- Exchange
- BMY Nasdaq
- BTI Nasdaq
- Market Cap
- BMY 95.0B
- BTI 113.4B
- IPO Year
- BMY N/A
- BTI N/A
- Fundamental
- Price
- BMY $47.23
- BTI $54.85
- Analyst Decision
- BMY Hold
- BTI Strong Buy
- Analyst Count
- BMY 11
- BTI 3
- Target Price
- BMY $55.64
- BTI $62.00
- AVG Volume (30 Days)
- BMY 16.4M
- BTI 4.0M
- Earning Date
- BMY 10-30-2025
- BTI 02-12-2026
- Dividend Yield
- BMY 5.27%
- BTI 5.54%
- EPS Growth
- BMY N/A
- BTI N/A
- EPS
- BMY 2.97
- BTI 1.89
- Revenue
- BMY $48,034,000,000.00
- BTI $35,067,817,512.00
- Revenue This Year
- BMY N/A
- BTI $0.01
- Revenue Next Year
- BMY N/A
- BTI $2.95
- P/E Ratio
- BMY $15.84
- BTI $29.08
- Revenue Growth
- BMY 1.26
- BTI N/A
- 52 Week Low
- BMY $42.52
- BTI $34.82
- 52 Week High
- BMY $63.33
- BTI $59.29
- Technical
- Relative Strength Index (RSI)
- BMY 57.46
- BTI 59.91
- Support Level
- BMY $46.12
- BTI $53.33
- Resistance Level
- BMY $49.99
- BTI $56.24
- Average True Range (ATR)
- BMY 1.29
- BTI 0.66
- MACD
- BMY 0.15
- BTI 0.19
- Stochastic Oscillator
- BMY 60.49
- BTI 75.00
About BMY Bristol-Myers Squibb Company
Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About BTI British American Tobacco Industries p.l.c. ADR
The third-largest tobacco company by volume, British American Tobacco sold 518 billion cigarettes in 2024. Its leading brands are Dunhill, Kent, Pall Mall, Lucky Strike, and Rothmans in cigarettes. Its ownership of the Camel, Natural American Spirit, and Newport brands are limited to the US. In next-generation products, the company has the Vuse brand in vaping, Glo in heated tobacco, and Velo in modern oral tobacco. The company also owns a 22.9% stake in ITC limited, the largest Indian cigarette company.